|
1
|
Shi X and Wang X, Yao W, Shi D, Shao X, Lu
Z, Chai Y, Song J, Tang W and Wang X: Mechanism insights and
therapeutic intervention of tumor metastasis: Latest developments
and perspectives. Signal Transduct Target Ther. 9:1922024.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kabakov A, Yakimova A and Matchuk O:
Molecular chaperones in cancer stem cells: Determinants of stemness
and potential targets for antitumor therapy. Cells. 9:8922020.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yang Y, Ma X, Li Y, Jin L and Zhou X: The
evolving tumor-associated adipose tissue microenvironment in breast
cancer: From cancer initiation to metastatic outgrowth. Clin Transl
Oncol. 27:2778–2788. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zellmer VR and Zhang S: Evolving concepts
of tumor heterogeneity. Cell Biosci. 4:692014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
de Visser KE and Joyce JA: The evolving
tumor microenvironment: From cancer initiation to metastatic
outgrowth. Cancer Cell. 41:374–403. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Prakash J and Shaked Y: The interplay
between extracellular matrix remodeling and cancer therapeutics.
Cancer Discov. 14:1375–1388. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bejarano L, Jordāo MJC and Joyce JA:
Therapeutic targeting of the tumor microenvironment. Cancer Discov.
11:933–959. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Noy R and Pollard JW: Tumor-associated
macrophages: From mechanisms to therapy. Immunity. 41:49–61. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mantovani A and Allavena P: The
interaction of anticancer therapies with tumor-associated
macrophages. J Exp Med. 212:435–445. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sun X, Gao D, Gao L, Zhang C, Yu X, Jia B,
Wang F and Liu Z: Molecular imaging of tumor-infiltrating
macrophages in a preclinical mouse model of breast cancer.
Theranostics. 5:597–608. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kalluri R and LeBleu VS: The biology,
function, and biomedical applications of exosomes. Science.
367:eaau69772020. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Guo W, Li Y, Pang W and Shen H: Exosomes:
A potential therapeutic tool targeting communications between tumor
cells and macrophages. Mol Ther. 28:1953–1964. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xu Z, Chen Y, Ma L, Chen Y, Liu J, Guo Y,
Yu T, Zhang L, Zhu L and Shu Y: Role of exosomal non-coding RNAs
from tumor cells and tumor-associated macrophages in the tumor
microenvironment. Mol Ther. 30:3133–3154. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Boelens MC, Wu TJ, Nabet BY, Xu B, Qiu Y,
Yoon T, Azzam DJ, Twyman-Saint Victor C, Wiemann BZ, Ishwaran H, et
al: Exosome transfer from stromal to breast cancer cells regulates
therapy resistance pathways. Cell. 159:499–513. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Romano R, Picca A, Eusebi LHU, Marzetti E,
Calvani R, Moro L, Bucci C and Guerra F: Extracellular vesicles and
pancreatic cancer: Insights on the roles of miRNA, lncRNA, and
protein cargos in cancer progression. Cells. 10:13612021.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xie Y, Dang W, Zhang S, Yue W, Yang L,
Zhai X, Yan Q and Lu J: The role of exosomal noncoding RNAs in
cancer. Mol Cancer. 18:372019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Han C, Zhang C, Wang H and Zhao L:
Exosome-mediated communication between tumor cells and
tumor-associated macrophages: Implications for tumor
microenvironment. Oncoimmunology. 10:18875522021. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Théry C, Witwer KW, Aikawa E, Alcaraz MJ,
Anderson JD, Andriantsitohaina R, Antoniou A, Arab T, Archer F,
Atkin-Smith GK, et al: Minimal information for studies of
extracellular vesicles 2018 (MISEV2018): A position statement of
the international society for extracellular vesicles and update of
the MISEV2014 guidelines. J Extracell Vesicles. 7:15357502018.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yuan Y, Jiang YC, Sun CK and Chen QM: Role
of the tumor microenvironment in tumor progression and the clinical
applications (review). Oncol Rep. 35:2499–2515. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang Q, Shao X, Zhang Y, Zhu M, Wang FXC,
Mu J, Li J, Yao H and Chen K: Role of tumor microenvironment in
cancer progression and therapeutic strategy. Cancer Med.
12:11149–11165. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yang E, Wang X, Gong Z, Yu M, Wu H and
Zhang D: Exosome-mediated metabolic reprogramming: The emerging
role in tumor microenvironment remodeling and its influence on
cancer progression. Signal Transduct Target Ther. 5:2422020.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Su T, Zhang P, Zhao F and Zhang S:
Exosomal MicroRNAs mediating crosstalk between cancer cells with
cancer-associated fibroblasts and tumor-associated macrophages in
the tumor microenvironment. Front Oncol. 11:6317032021. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dallavalasa S, Beeraka NM, Basavaraju CG,
Tulimilli SV, Sadhu SP, Rajesh K, Aliev G and Madhunapantula SV:
The role of tumor associated macrophages (TAMs) in cancer
progression, chemoresistance, angiogenesis and metastasis-current
status. Curr Med Chem. 28:8203–8236. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Fu LQ, Du WL, Cai MH, Yao JY, Zhao YY and
Mou XZ: The roles of tumor-associated macrophages in tumor
angiogenesis and metastasis. Cell Immunol. 353:1041192020.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang Y, Zhang J, Shi H, Wang M, Yu D, Fu
M, Qian Y, Zhang X, Ji R, Wang S, et al: M2 tumor-associated
macrophages-derived exosomal MALAT1 promotes glycolysis and gastric
cancer progression. Adv Sci (Weinh). 11:e23092982024. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Meng Z, Zhang R, Wu X, Piao Z, Zhang M and
Jin T: LncRNA HAGLROS promotes breast cancer evolution through
miR-135b-3p/COL10A1 axis and exosome-mediated macrophage M2
polarization. Cell Death Dis. 15:6332024. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Deng C, Huo M, Chu H, Zhuang X, Deng G, Li
W, Wei H, Zeng L, He Y, Liu H, et al: Exosome circATP8A1 induces
macrophage M2 polarization by regulating the miR-1-3p/STAT6 axis to
promote gastric cancer progression. Mol Cancer. 23:492024.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang W, Wang M, Ji C, Liu X, Gu B and
Dong T: Macrophage polarization in the tumor microenvironment:
Emerging roles and therapeutic potentials. Biomed Pharmacother.
177:1169302024. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Müller E, Christopoulos PF, Halder S,
Lunde A, Beraki K, Speth M, Øynebråten I and Corthay A: Toll-like
receptor ligands and interferon-γ synergize for induction of
antitumor M1 macrophages. Front Immunol. 8:13832017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Figueiredo P, Lepland A, Scodeller P,
Fontana F, Torrieri G, Tiboni M, Shahbazi MA, Casettari L,
Kostiainen MA, Hirvonen J, et al: Peptide-guided resiquimod-loaded
lignin nanoparticles convert tumor-associated macrophages from M2
to M1 phenotype for enhanced chemotherapy. Acta Biomater.
133:231–243. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chen C, Yao X, Xu Y, Zhang Q, Wang H, Zhao
L, Wen G, Liu Y, Jing L and Sun X: Dahuang Zhechong pill suppresses
colorectal cancer liver metastasis via ameliorating exosomal CCL2
primed pre-metastatic niche. J Ethnopharmacol. 238:1118782019.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang S, Yang W, Peng T, Zhu C, Dong J,
Wang Y, Yuan H, Sun Q, Luan X, Guan X, et al: IFN-γ-driven UBE2D3
upregulation impairs antigen presentation pathways and anti-tumor
immunity in pancreatic cancer. Nat Commun. 16:107332025. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Pan Z, Bao J, Zhang L and Wei S: UBE2D3
activates SHP-2 ubiquitination to promote glycolysis and
proliferation of glioma via regulating STAT3 signaling pathway.
Front Oncol. 11:6742862021. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Guan GG, Wang WB, Lei BX, Wang QL, Wu L,
Fu ZM, Zhou FX and Zhou YF: UBE2D3 is a positive prognostic factor
and is negatively correlated with hTERT expression in esophageal
cancer. Oncol Lett. 9:1567–1574. 2015. View Article : Google Scholar : PubMed/NCBI
|
